Robert Stratta to Ganciclovir
This is a "connection" page, showing publications Robert Stratta has written about Ganciclovir.
Connection Strength
0.845
-
Stratta RJ, Rohr MS, Adams PL, Sundberg AK, Hartmann EL, Armstrong G, Anderson TK, Farney AC, Roskopf JA, Hairston G, Kiger DF, Nagaraj SK, Iskandar SS, Assimos DG. Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. Clin Transpl. 2003; 229-45.
Score: 0.217
-
Somerville T, Hurst G, Alloway R, Gaber A, Shokouh-Amiri MH, Stratta R. Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients. Transplant Proc. 1998 Jun; 30(4):1546-8.
Score: 0.158
-
Stratta RJ. Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation. Transplant Proc. 1998 Mar; 30(2):262.
Score: 0.155
-
Stratta R, Shaefer M, Markin R, Bradshaw K, Donovan J, Wood R, Langnas A, Reed E, Woods G, Zetterman R, et al. Ganciclovir therapy for viral disease in liver transplant recipients. Transplant Proc. 1991 Jun; 23(3):1968.
Score: 0.097
-
Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis. 2001 Mar; 3(1):8-15.
Score: 0.048
-
Lo A, Stratta RJ, Egidi MF, Kizilisik AT, Shokouh-Amiri MH, Grewal HP, Trofe J, Alloway RR, Gaber AO. Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. Transplant Proc. 2001 Feb-Mar; 33(1-2):1796-8.
Score: 0.047
-
Shaefer MS, Stratta RJ, Markin RS, Cushing KA, Woods GL, Reed EC, Wood RP, Langnas AN, Shaw BW. Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1515-6.
Score: 0.024
-
Markin RS, Langnas AN, Donovan JP, Zetterman RK, Stratta RJ. Opportunistic viral hepatitis in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1520-1.
Score: 0.024
-
Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Wood RP, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation. 1991 Jan; 51(1):90-7.
Score: 0.024
-
Stratta RJ, Shaefer MS, Markin RS, Wood RP, Kennedy EM, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg. 1989 Dec; 124(12):1443-9; discussion 1449-50.
Score: 0.022
-
Hartmann EL, Gatesman M, Roskopf-Somerville J, Stratta R, Farney A, Sundberg A. Management of leukopenia in kidney and pancreas transplant recipients. Clin Transplant. 2008 Nov-Dec; 22(6):822-8.
Score: 0.020
-
D'Alessandro AM, Pirsch JD, Stratta RJ, Sollinger HW, Kalayoglu M, Belzer FO. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. Transplant Proc. 1989 Jun; 21(3):3560-1.
Score: 0.005
-
Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Alessandro AM, Kalayoglu M, Belzer FO. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med. 1989 Feb; 86(2):241-4.
Score: 0.005